From Sleep to Genomics: Truway Health Advances Precision Health Through Its First ClinVar Submission
June 4, 2026
By Truway Health Research & Innovation Team
At Truway Health, we believe that the future of healthcare will be built upon a deeper understanding of the biological systems that govern how we think, recover, perform, and adapt.
Today, we are proud to announce a significant milestone in that journey: the successful pre-validation and processing acceptance of our inaugural ClinVar submission associated with the Sleep Architecture, Neurocognitive Performance, and Circadian Genomics Registry (NFHST-GENOME).
This submission represents the first genomic contribution from our ongoing NeuroFinance Human Stress Trial During Financial and Informational Volatility (NFHST), a research initiative designed to explore the relationships among sleep, cognition, stress adaptation, circadian biology, and human performance.
Why Sleep Matters More Than Ever
Sleep is not simply a period of rest. It is an active biological process that influences nearly every major system within the human body.
Researchers continue to uncover connections between sleep quality and:
-
Cognitive performance
-
Memory consolidation
-
Emotional regulation
-
Cardiovascular health
-
Immune function
-
Metabolic efficiency
-
Longevity and healthy aging
Despite these discoveries, important questions remain regarding how genetics influences individual differences in sleep timing, resilience to sleep loss, recovery rates, and overall cognitive performance.
The NFHST-GENOME initiative was created to help answer those questions.
Introducing NFHST-GENOME
The Sleep Architecture, Neurocognitive Performance, and Circadian Genomics Registry (NFHST-GENOME) is a longitudinal precision-health registry that integrates multiple streams of biological information into a unified research framework.
The registry combines:
Sleep Architecture
-
REM sleep dynamics
-
Slow-wave sleep patterns
-
Sleep efficiency
-
Sleep fragmentation
-
Autonomic nervous system activity
Neurocognitive Performance
-
Executive function
-
Vigilance
-
Working memory
-
Cognitive flexibility
-
Reaction-time variability
Circadian Biology
-
Chronotype analysis
-
Circadian timing markers
-
Clock-gene pathways
-
Sleep-wake regulation
Genomics
-
Germline genomic variants
-
Circadian pathway markers
-
Neuroplasticity-associated genes
-
Sleep-related genetic signatures
Together, these datasets provide a powerful foundation for understanding how biological variability contributes to differences in human performance and recovery.
A New Step Into Genomic Research
As part of this initiative, Truway Health completed its first ClinVar submission through the National Center for Biotechnology Information (NCBI).
ClinVar serves as a public archive that supports the interpretation of genomic variation and its relationship to human health and disease.
The successful processing of our submission establishes:
-
Genomic data governance infrastructure
-
Variant interpretation workflows
-
Registry-based evidence generation capabilities
-
Long-term precision-health research pathways
This milestone positions NFHST-GENOME for future expansion into broader genomic discovery efforts.
Building a Multi-Domain Human Performance Model
The future of healthcare will likely move beyond isolated measurements toward integrated models that evaluate the whole person.
Our vision includes connecting:
-
Sleep physiology
-
Genomic information
-
Behavioral patterns
-
Environmental exposures
-
Cognitive performance
-
Recovery metrics
By integrating these domains, researchers may be able to develop more accurate methods for predicting fatigue, identifying resilience factors, and optimizing recovery.
Future Areas of Discovery
The NFHST-GENOME roadmap extends beyond traditional sleep research.
Future investigations may include:
Circadian Genomics
Exploring how clock genes influence daily performance, recovery, and adaptation.
Neuroplasticity
Understanding how sleep-dependent learning and memory processes vary among individuals.
Precision Sleep Medicine
Developing individualized approaches to sleep health based on biological and genomic profiles.
Multi-Omics Integration
Combining genomic, transcriptomic, epigenetic, and physiologic data into unified analytical frameworks.
Digital Health and Predictive Analytics
Applying machine learning and advanced modeling techniques to identify performance and recovery patterns.
Human Resilience Research
Investigating how individuals respond differently to stress, sleep disruption, travel, shift work, and demanding cognitive environments.
Looking Forward
The successful ClinVar submission marks only the beginning of a larger effort to better understand the biological foundations of human performance.
As NFHST-GENOME continues to grow, Truway Health remains committed to advancing research at the intersection of sleep science, circadian biology, genomics, and precision health.
Our goal is simple:
To help transform biological data into actionable knowledge that improves health, resilience, recovery, and quality of life.
The future of healthcare is personalized, data-driven, and increasingly connected to our understanding of sleep and circadian biology.
We are excited to be part of that future.
Program: NeuroFinance Human Stress Trial During Financial and Informational Volatility (NFHST)
Registry: Sleep Architecture, Neurocognitive Performance, and Circadian Genomics Registry (NFHST-GENOME)
Sponsor: Truway Health, Inc.
Protocol ID: NFHST-2026-001
ClinicalTrials.gov Identifier: NCT07622589
Truway Health News & Insights
TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intelligence Research Program
PRESS RELEASE TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intellige...
Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective Study Examining “Clinical Time” and Temporal Dynamics in Patient Health
PRESS RELEASE Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective...
TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deterioration
TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deteri...
Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Resilience Study
FOR IMMEDIATE RELEASE Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Re...
Choosing Surgical Loupes: 2.5× vs. 3.5× Magnification
Surgical loupes provide a magnified view of the working area, helping healthcare professionals see f...
TruWay Health Announces Registration of New Research Protocol for Federated Learning in Point-of-Care Cardiac Ultrasound
Protocol establishes a privacy-conscious framework for multi-site research integrating point-of-care...